Team:SJTU-BioX-Shanghai/Project/Subproject3
From 2011.igem.org
(Difference between revisions)
(→Design) |
(→Results) |
||
Line 49: | Line 49: | ||
''metY''-CGA: We have cloned operon ''metY'' containing tRNA<sup>Met</sup> from ''E.coli'' to pACYC184. The anticodon of tRNA<sup>Met</sup> was mutated to TCG (base pairing codon CGA). | ''metY''-CGA: We have cloned operon ''metY'' containing tRNA<sup>Met</sup> from ''E.coli'' to pACYC184. The anticodon of tRNA<sup>Met</sup> was mutated to TCG (base pairing codon CGA). | ||
- | We inserted ''bla'' operon from pUC18 into pET28a, endowing pET28a with | + | We inserted ''bla'' operon from pUC18 into pET28a, endowing pET28a with Kan and Amp resistance. Then the start codon of KanR gene is mutated from ATG to CGA. We then inserted MetRS obtained from error-prone PCR into the MCS of this pET28a. When this plasmid is co-transformed with ''metY''-CGA, we can screen the mutants with Kanamycin resistance. The same method is also used to test the function of the truncated MetRS PT7-''metG''N ([http://partsregistry.org/wiki/index.php?title=Part:BBa_K567015 BBa_K567015]). |
We screened the MetRS obtained through error-prone PCR and obtained one target mutant. We have also tested the activity of the truncated MetRS PT7-''metG''N ([http://partsregistry.org/wiki/index.php?title=Part:BBa_K567015 BBa_K567015])and found that the truncated MetRS acted as expected, losing specificity for tRNA<sup>Met</sup> anticodon while maintaining aminoacylation ability. | We screened the MetRS obtained through error-prone PCR and obtained one target mutant. We have also tested the activity of the truncated MetRS PT7-''metG''N ([http://partsregistry.org/wiki/index.php?title=Part:BBa_K567015 BBa_K567015])and found that the truncated MetRS acted as expected, losing specificity for tRNA<sup>Met</sup> anticodon while maintaining aminoacylation ability. | ||
- | [[image:11SJTU-initial_codon_result.jpg|frame|center|''Fig 2.'' Growth of ER2566 with a. ''metG''N + ''metY''-CGA, b. ''metG''M + ''metY''-CGA, c. + ''metG''N, d. + ''metG''M. Growth medium (left): LB Kana+Tet. Growth medium (right): LB | + | [[image:11SJTU-initial_codon_result.jpg|frame|center|''Fig 2.'' Growth of ER2566 with a. ''metG''N + ''metY''-CGA, b. ''metG''M + ''metY''-CGA, c. + ''metG''N, d. + ''metG''M. Growth medium (left): LB Kana+Tet. Growth medium (right): LB Kanamycin.]] |
- | Cell growth shows that the cells have | + | Cell growth shows that the cells have Kanamycin resistance only when both modified MetRS (''metG''N or ''metG''M) and modified tRNA<sup>Met</sup>(''metY''-CGA) are transformed into the cell, '''proving that tRNA ''metY''-CGA can transfer fMet to CGA when it is used as the start codon and that ''metG''N and ''metG''M work well. ''' |
'''Initial-Codon Switch proved successful. ''' | '''Initial-Codon Switch proved successful. ''' |
Revision as of 18:56, 28 October 2011